Physical health status and nocturnal hypoglycaemia with insulin degludec vs insulin glargine: a 2-year trial in insulin-naive patients with type 2 diabetes

被引：0
|
作者：
Handelsman, Y.
Cariou, B. [1 ]
Rodbard, H. W. [2 ]
Zinman, B. [3 ]
Wolden, M. L. [4 ]
Rana, A. [4 ]
Mathieu, C. [5 ]
机构：
[1] Nantes Univ Hosp, Nantes, France
[2] Endocrine & Metab Consultants, Rockville, MD USA
[3] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[4] Novo Nordisk AS, Soborg, Denmark
[5] UZ Leuven, Louvain, Belgium
来源：
DIABETOLOGIA | 2013年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1050
引用
收藏
页码：S422 / S422
页数：1
相关论文
共 50 条
  • [1] Physical Health Status and Nocturnal Hypoglycemia With Insulin Degludec vs. Insulin Glargine: A 2-Year Trial in Insulin-Naive Patients With Type 2 Diabetes
    Rodbard, Helena W.
    Cariou, Bertrand
    Zinman, Bernard
    Han-Delsman, Yehuda
    Wolden, Michael L.
    Rana, Azhar
    Mathieu, Chantal
    [J]. DIABETES, 2013, 62 : A237 - A238
  • [2] Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naive patients with type 2 diabetes
    Rodbard, H. W.
    Cariou, B.
    Zinman, B.
    Handelsman, Y.
    Wolden, M. L.
    Rana, A.
    Mathieu, C.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (09): : 869 - 872
  • [3] Effect of insulin degludec on glycaemic control and nocturnal hypoglycaemia compared with insulin glargine: a 1-year trial in insulin-naive patients with type 2 diabetes
    Zinman, B.
    Philis-Tsimikas, A.
    Handelsman, Y.
    Rodbard, H. W.
    Cariou, B.
    Johansen, T.
    Endahl, L.
    Mathieu, C.
    [J]. DIABETOLOGIA, 2012, 55 : S22 - S22
  • [4] Reduced nocturnal hypoglycaemia with insulin degludec vs insulin glargine: a two year trial in Type 2 diabetes
    Cariou, B.
    Rodbard, H.
    Zinman, B.
    Philis-Tsimikas, A.
    Handlesman, Y.
    Skoth, T. V.
    Chu, P-L
    Mathieu, C.
    [J]. DIABETIC MEDICINE, 2013, 30 : 55 - 55
  • [5] Insulin Degludec Reduces Hypoglycemia and Improves Health Status vs. Insulin Glargine in Insulin-Naive Type 2 Diabetes
    Rodbard, Helena W.
    Handelsman, Yehuda
    Cariou, Bertrand
    Johansen, Thue
    Christensen, Torsten E.
    Mathieu, Chantal
    [J]. DIABETES, 2012, 61 : A307 - A308
  • [6] Reduced nocturnal hypoglycaemia with insulin degludec as compared to insulin glargine: results of a 2-year randomised trial in type 2 diabetes
    Rodbard, H. W.
    Zinman, B.
    Cariou, B.
    Philis-Tsimikas, A.
    Handelsman, Y.
    Skjoth, T. V.
    Chu, P. -L.
    Mathieu, C.
    [J]. DIABETOLOGIA, 2012, 55 : S378 - S378
  • [7] Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial
    Rodbard, H. W.
    Cariou, B.
    Zinman, B.
    Handelsman, Y.
    Philis-Tsimikas, A.
    Skjoth, T. V.
    Rana, A.
    Mathieu, C.
    [J]. DIABETIC MEDICINE, 2013, 30 (11) : 1298 - 1304
  • [8] Insulin degludec in Insulin-Naive Type 2 Diabetics - Lower Nocturnal Hypoglycaemia Rate
    Merker, L.
    Wilhelm, B.
    Kaiser, M.
    Segiet, T.
    Pfeiffer, A. F. H.
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2013, 22 (06): : 377 - 384
  • [9] 7.2 Physical Health Status and Nocturnal Hypoglycemia with Insulin Degludec vs. Insulin Glargine: A 2-Year Trial in Insulin-Naïve Patients with Type 2 Diabetes (934-P)
    Helena W. Rodbard
    Bertrand Cariou
    Bernard Zinman
    Yehuda Handelsman
    Michael L. Wolden
    Azhar Rana
    Chantal Mathieu
    [J]. Nederlands Tijdschrift voor Diabetologie, 2013, 11 (3) : 98 - 99
  • [10] The Effect of Insulin Degludec on Glycemic Control and Nocturnal Hypoglycemia Compared With Insulin Glargine: A 1-Year Randomized Trial in Insulin-Naive People With Type 2 Diabetes
    Zinman, Bernard
    Philis-Tsimikas, Athena
    Handelsman, Yehuda
    Rodbard, Helena W.
    Cariou, Bertrand
    Johansen, Thue
    Endahl, Lars
    Mathieu, Chantal
    [J]. DIABETES, 2012, 61 : A269 - A269
12345